To include your compound in the COVID-19 Resource Center, submit it here.

KHK7580: Phase IIb started

Kyowa began a double-blind, placebo-controlled, Japanese Phase IIb trial to compare 3 dose levels of oral KHK7580

Read the full 175 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE